• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用携带致病性线粒体 DNA 突变的患者样本创建细胞模型 2.0:LHON 的 iPSC 方法。

Creating Cell Model 2.0 Using Patient Samples Carrying a Pathogenic Mitochondrial DNA Mutation: iPSC Approach for LHON.

机构信息

Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.

Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.

出版信息

Methods Mol Biol. 2022;2549:219-231. doi: 10.1007/7651_2021_384.

DOI:10.1007/7651_2021_384
PMID:34669166
Abstract

Leber's Hereditary Optic Neuropathy is the most prevalent mitochondrial neurological disease caused by mutations in mitochondrial DNA encoded respiratory complex I subunits. Although the genetic origin for Leber's hereditary optic neuropathy was identified about 30 years ago, the underlying pathogenesis is still unclear primarily due to the lack of a relevant system or cell model. Current models are limited to lymphoblasts, fibroblasts, or cybrid cell lines. As the disease phenotype is limited to retinal ganglion cells, induced pluripotent stem cells will serve as an excellent model for studying this tissue-specific disease, elucidating its underlying molecular mechanisms, and identifying novel therapeutic targets. Here, we describe a detailed protocol for the generation of retinal ganglion cells, and also cardiomyocytes for proof of iPSC pluripotency.

摘要

Leber 遗传性视神经病变是最常见的线粒体神经系统疾病,由线粒体 DNA 编码的呼吸复合物 I 亚单位突变引起。尽管 Leber 遗传性视神经病变的遗传起源大约在 30 年前就已经确定,但由于缺乏相关的系统或细胞模型,其潜在的发病机制仍不清楚。目前的模型仅限于淋巴母细胞、成纤维细胞或杂种细胞系。由于疾病表型仅限于视网膜神经节细胞,诱导多能干细胞将成为研究这种组织特异性疾病的理想模型,阐明其潜在的分子机制,并确定新的治疗靶点。在这里,我们描述了生成视网膜神经节细胞的详细方案,以及用于证明 iPSC 多能性的心肌细胞。

相似文献

1
Creating Cell Model 2.0 Using Patient Samples Carrying a Pathogenic Mitochondrial DNA Mutation: iPSC Approach for LHON.使用携带致病性线粒体 DNA 突变的患者样本创建细胞模型 2.0:LHON 的 iPSC 方法。
Methods Mol Biol. 2022;2549:219-231. doi: 10.1007/7651_2021_384.
2
Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy.莱伯遗传性视神经病变诱导多能干细胞模型中的线粒体替代
Aging (Albany NY). 2017 Apr;9(4):1341-1350. doi: 10.18632/aging.101231.
3
Generation of an induced pluripotent stem cell line from a patient with leber's hereditary optic neuropathy carrying a homoplasmic m.3635G > A mutation in the mitochondrial ND1 gene.从一位携带线粒体 ND1 基因中 m.3635G>A 突变的同质性纯合子的 Leber 遗传性视神经病变患者中诱导产生多能干细胞系。
Stem Cell Res. 2022 Aug;63:102858. doi: 10.1016/j.scr.2022.102858. Epub 2022 Jul 12.
4
Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber's hereditary optic neuropathy.MT-ND4 突变的莱伯遗传性视神经病变中 hiPSC 生成的视网膜神经节细胞的生物活性和基因表达谱。
Exp Cell Res. 2018 Feb 15;363(2):299-309. doi: 10.1016/j.yexcr.2018.01.020.
5
Nuclear modifier YARS2 allele correction restored retinal ganglion cells-specific deficiencies in Leber's hereditary optic neuropathy.核修饰基因 YARS2 等位基因校正恢复莱伯遗传性视神经病变中视网膜神经节细胞特异性缺陷。
Hum Mol Genet. 2023 Apr 20;32(9):1539-1551. doi: 10.1093/hmg/ddad001.
6
Inhibition of angiogenesis by the secretome from iPSC-derived retinal ganglion cells with Leber's hereditary optic neuropathy-like phenotypes.iPSC 衍生的具有 Leber 遗传性视神经病变样表型的视网膜神经节细胞分泌组抑制血管生成。
Biomed Pharmacother. 2024 Sep;178:117270. doi: 10.1016/j.biopha.2024.117270. Epub 2024 Aug 11.
7
Generation of a human iPSC line, FINCBi001-A, carrying a homoplasmic m.G3460A mutation in MT-ND1 associated with Leber's Hereditary optic Neuropathy (LHON).生成携带与Leber遗传性视神经病变(LHON)相关的MT-ND1基因m.G3460A纯合突变的人诱导多能干细胞系FINCBi001-A。
Stem Cell Res. 2020 Oct;48:101939. doi: 10.1016/j.scr.2020.101939. Epub 2020 Aug 3.
8
Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.新兴的 Leber 遗传性视神经病变模型系统和治疗方法:挑战与机遇。
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165743. doi: 10.1016/j.bbadis.2020.165743. Epub 2020 Feb 24.
9
The pathological mechanisms and novel therapeutics for Leber's hereditary optic neuropathy.Leber 遗传性视神经病变的病理机制和新疗法。
J Chin Med Assoc. 2023 Jun 1;86(6):539-541. doi: 10.1097/JCMA.0000000000000927. Epub 2023 Apr 10.
10
Mitophagy activation repairs Leber's hereditary optic neuropathy-associated mitochondrial dysfunction and improves cell survival.自噬激活修复莱伯遗传性视神经病变相关的线粒体功能障碍并提高细胞存活率。
Hum Mol Genet. 2019 Feb 1;28(3):422-433. doi: 10.1093/hmg/ddy354.

引用本文的文献

1
Mitochondrial impairment and synaptic dysfunction are associated with neurological defects in iPSCs-derived cortical neurons of MERRF patients.线粒体功能障碍和突触功能障碍与 MERRF 患者诱导多能干细胞衍生皮质神经元的神经缺陷有关。
J Biomed Sci. 2023 Aug 21;30(1):70. doi: 10.1186/s12929-023-00966-8.
2
Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber's hereditary optic neuropathy patients.超氧化物歧化酶2改善Leber遗传性视神经病变患者皮肤成纤维细胞中的线粒体功能障碍。
Front Neurosci. 2022 Aug 9;16:917348. doi: 10.3389/fnins.2022.917348. eCollection 2022.
3
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics.

本文引用的文献

1
Identification of potential transcription factors that enhance human iPSC generation.鉴定可增强人诱导多能干细胞生成的潜在转录因子。
Sci Rep. 2020 Dec 15;10(1):21950. doi: 10.1038/s41598-020-78932-9.
2
Leber Hereditary Optic Neuropathy: Exemplar of an mtDNA Disease.Leber遗传性视神经病变:线粒体DNA疾病的范例
Handb Exp Pharmacol. 2017;240:339-376. doi: 10.1007/164_2017_2.
3
Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration.从人类多能干细胞逐步分化视网膜神经节细胞有助于青光眼神经退行性变的分析。
衰老与疾病中的线粒体基因组及线粒体治疗的未来
Biomedicines. 2022 Feb 18;10(2):490. doi: 10.3390/biomedicines10020490.
Stem Cells. 2016 Jun;34(6):1553-62. doi: 10.1002/stem.2356. Epub 2016 Mar 21.
4
Skin Biopsy and Patient-Specific Stem Cell Lines.皮肤活检与患者特异性干细胞系
Methods Mol Biol. 2016;1353:77-88. doi: 10.1007/7651_2015_225.
5
Ophthalmological manifestations in patients with Leigh syndrome.Leigh综合征患者的眼科表现。
Br J Ophthalmol. 2015 Apr;99(4):528-35. doi: 10.1136/bjophthalmol-2014-305704. Epub 2014 Oct 28.
6
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.一种高效的非病毒方法,可从脐血和外周血细胞中生成无整合的人诱导多能干细胞。
Stem Cells. 2013 Mar;31(3):458-66. doi: 10.1002/stem.1293.
7
Mitochondrial disorders with significant ophthalmic manifestations.伴有明显眼部表现的线粒体疾病。
Middle East Afr J Ophthalmol. 2008 Apr;15(2):81-6. doi: 10.4103/0974-9233.51998.
8
Mitochondrial DNA and disease.线粒体DNA与疾病
Ann Med. 2005;37(3):222-32. doi: 10.1080/07853890510007368.
9
Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium.莱伯遗传性视神经病变(LHON)致病突变在与半乳糖培养基孵育的转线粒体细胞中诱导线粒体依赖性凋亡死亡。
J Biol Chem. 2003 Feb 7;278(6):4145-50. doi: 10.1074/jbc.M210285200. Epub 2002 Nov 21.
10
Leber hereditary optic neuropathy.莱伯遗传性视神经病变
J Med Genet. 2002 Mar;39(3):162-9. doi: 10.1136/jmg.39.3.162.